Evidence map›Paper›PMID 26197243›Full record

Trial reportRedox report : communications in free radical research2016

LINE-1 methylation levels, a biomarker of weight loss in obese subjects, are influenced by dietary antioxidant capacity.

Marcos Garcia-Lacarte, Fermin I Milagro, Maria A Zulet, J Alfredo Martinez, Maria L Mansego

Registry-linked trialOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Redox report : communications in free radical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01087086 (Reduction of the Metabolic Syndrome in Navarra-Spain), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01087086 nacompletednot on this map

Reduction of the Metabolic Syndrome in Navarra-Spain (RESMENA-S) Through an Innovative Multidisciplinary Strategy Based on the Crononutrition and Dietary Training Concepts, in Addition to Both Dietary and Psychological Control

TypeinterventionalSponsorClinica Universidad de Navarra, Universidad de NavarraRan2010 to 2011Enrolled109ConditionsMetabolic Syndrome, Obesity, Diabetes, Cardiovascular DiseaseArmsCrononutrition, American Heart Association
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Epigenetics, microRNA and Metabolic Syndrome: A Comprehensive Review.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marcos Garcia-Lacartea Department of Nutrition , Food Science and Physiology, Centre for Nutrition Research, University of Navarra , Pamplona , Spain.
Fermin I Milagroa Department of Nutrition , Food Science and Physiology, Centre for Nutrition Research, University of Navarra , Pamplona , Spain.
Maria A Zuleta Department of Nutrition , Food Science and Physiology, Centre for Nutrition Research, University of Navarra , Pamplona , Spain.
J Alfredo Martineza Department of Nutrition , Food Science and Physiology, Centre for Nutrition Research, University of Navarra , Pamplona , Spain.
Maria L Mansegoa Department of Nutrition , Food Science and Physiology, Centre for Nutrition Research, University of Navarra , Pamplona , Spain.
Centro de Investigación Biomédica en Red · ESUniversidad de Navarra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesEpigenetic markers, and in particular DNA methylation, have come to the fore as new tools in the personalization of the treatment of obesity and its comorbidities. The objectives of the current investigation were to identify epigenetic biomarkers that might be predictive of response to a weight-loss intervention, and to better understand the influence of certain nutrients (particularly antioxidants) on the epigenome.

methodsGlobal DNA (LINE-1) methylation levels were assessed in peripheral blood mononuclear cells (PBMCs) from 96 obese volunteers of the Metabolic Syndrome Reduction in Navarra study, using a methylation-sensitive high resolution melting approach after bisulfite modification.

resultsBaseline LINE-1 DNA methylation levels were significantly higher (5.41%) in high responders (>8% of weight loss) as compared to low responders (<8%) to the energy-restricted treatment. Indeed, a LINE-1 methylation higher than 84.15% may be predictive of a high response to the hypocaloric diet. Statistically significant correlations were found between LINE-1 baseline DNA methylation levels and the response to the treatment involving total fat mass and body weight. Furthermore, LINE-1 baseline methylation levels positively correlated with baseline dietary total antioxidant capacity (TAC). DISCUSSION: LINE-1 methylation levels in PBMCs might be used to predict response to a dietary weight-loss intervention, and seem to be related to the dietary TAC.

trial registrationwww.clinicaltrials.gov : NCT01087086.

Indexed as

AntioxidantsBiomarkersDiet, ReducingDNA MethylationFemaleHumansLong Interspersed Nucleotide ElementsMaleObesityWeight LossAntioxidantsBiomarkersAntioxidantsBiomarkersEnergy-restrictionEpigeneticLINE-1MethylationObesity

Identifiers

PMID26197243
PMCPMC6837392
OpenAlexW1499097195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.